Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David O'Dwyer"'
Publikováno v:
Annals of the American Thoracic Society. 20:136-139
Autor:
Christina L. Porter, Teis Coenen, Niels Geypen, Sandy Scholz, Loes van Rijswijk, Han-Kwang Nienhuys, Jeroen Ploegmakers, Johan Reinink, Hugo Cramer, Rik van Laarhoven, David O'Dwyer, Peter Smorenburg, Andrea Invernizzi, Ricarda Wohrwag, Hugo Jonquiere, Juliane Reinhardt, Omar El Gawhary, Simon G. J. Mathijssen, Peter D. Engblom, Heidi Chin, William T. Blanton, Sury Ganesan, Brian J. Krist, Florian Gstrein, Mark Phillips
Publikováno v:
Metrology, Inspection, and Process Control XXXVII.
Autor:
Ahmad Ramahi, Alain Lescoat, David Roofeh, Vivek Nagaraja, Rajaie Namas, Suiyuan Huang, John Varga, David O’Dwyer, Bonnie Wang, Kevin Flaherty, Ella Kazerooni, Dinesh Khanna
Publikováno v:
Rheumatology
Rheumatology, 2022, ⟨10.1093/rheumatology/keac639⟩
Rheumatology, 2022, ⟨10.1093/rheumatology/keac639⟩
Objectives The aim of this study was to identify risk factors of percent predicted forced vital capacity (ppFVC) decline in patients with SSc-associated interstitial lung disease (SSc-ILD). Methods We identified 484 patients with SSc who had HRCT Che
Autor:
Aisling, Tynan, Leona, Mawhinney, Michelle E, Armstrong, Ciaran, O'Reilly, Sarah, Kennedy, Emma, Caraher, Karen, Jülicher, David, O'Dwyer, Lewena, Maher, Kirsten, Schaffer, Aurélie, Fabre, Edward F, McKone, Lin, Leng, Richard, Bucala, Jürgen, Bernhagen, Gordon, Cooke, Seamas C, Donnelly
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 31(11)
Macrophage migration inhibitory factor (MIF) is a key proinflammatory mediator that we have previously shown to be associated with an aggressive clinical phenotype in cystic fibrosis. It possesses unique tautomerase enzymatic activity. However, to da